How to Help Kids Sleep Better – Sleep Researcher Puts Common Misconceptions to Rest

Sleep is an important part of physical and mental health, especially in school-age children and adolescents. A well-rounded sleep schedule supports healthy brain function, maintains physical and emotional balance and reduces the risk of long-term health problems. Unfortunately, about 30% of parents say their kids are not getting enough shut-eye. While sleep challenges vary, research […]

Read More →

Focusing Care – ADHD Expert Shares Current Treatments and Latest Research at Seattle Children’s

Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders that affect children. While patients may first be diagnosed in childhood, ADHD often persists and can be diagnosed at any age. Management of the condition varies as symptoms manifest differently through various milestones in a person’s life. Common ADHD symptoms include trouble […]

Read More →

Everything You Need to Know About Fall and Winter Vaccinations – Q&A with Seattle Children’s Pediatric Infectious Disease Research Group

As summer starts to cool down, parents are all too familiar with the return of back to school prep and fun fall activities. While families are busy checking off school supply lists and spending more time indoors through the chillier months, it might be easy to overlook the preventive care to help keep children safe […]

Read More →

Research Highlights: Equity Initiatives Improve Infection Rates; Cell and Gene Therapy Progress; Malaria Study

As one of the nation’s top four pediatric research centers, Seattle Children’s Research Institute remains dedicated to providing hope, care and cures to help every child live the healthiest and most fulfilling life possible. On the Pulse takes a look at some of the highlights from across the research institute over the past month.  

Read More →

Seattle Children’s Research Featured in Worldwide Study on COVID-19 Vaccine Safety in Young Children

New findings from Seattle Children’s Research Institute’s Center for Clinical and Translational Research reveal that a three-dose primary series of Pfizer’s COVID-19 vaccine was safe and effective in children 6 months to 4 years of age, even when a new variant (Omicron) was circulating. The findings were released on Feb. 16 in the New England […]

Read More →